Compile Data Set for Download or QSAR
Report error Found 344 of affinity data for UniProtKB/TrEMBL: P26664
TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241823(US9416139, 2 | US9416139, 1)
Affinity DataEC50:  0.760nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241823(US9416139, 2 | US9416139, 1)
Affinity DataEC50:  1.28nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241825(US9416139, 3)
Affinity DataEC50:  0.537nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241826(US9416139, 4)
Affinity DataEC50:  0.0890nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241827(US9416139, 5)
Affinity DataEC50:  0.0780nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241828(US9416139, 6)
Affinity DataEC50:  0.109nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241829(US9416139, 7)
Affinity DataEC50:  0.210nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241830(US9416139, 8)
Affinity DataEC50:  0.982nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241831(US9416139, 9)
Affinity DataEC50:  0.439nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241832(US9416139, 11 | US9416139, 10)
Affinity DataEC50:  1.27nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241832(US9416139, 11 | US9416139, 10)
Affinity DataEC50:  0.0680nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241834(US9416139, 12)
Affinity DataEC50:  0.380nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241835(US9416139, 13)
Affinity DataEC50:  2.07nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241836(US9416139, 14)
Affinity DataEC50:  0.884nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241837(US9416139, 15)
Affinity DataEC50:  0.206nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241838(US9416139, 16)
Affinity DataEC50:  0.0890nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241839(US9416139, 17)
Affinity DataEC50:  0.0230nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241840(US9416139, 18)
Affinity DataEC50:  0.326nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241841(US9416139, 19)
Affinity DataEC50:  4.77nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241842(US9416139, 20)
Affinity DataEC50:  3.67nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241843(US9416139, 21)
Affinity DataEC50:  0.0800nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241844(US9416139, 22)
Affinity DataEC50:  0.561nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241845(US9416139, 23)
Affinity DataEC50:  0.310nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241846(US9416139, 24)
Affinity DataEC50:  0.475nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241847(US9416139, 25)
Affinity DataEC50:  0.829nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241848(US9416139, 26)
Affinity DataEC50:  0.727nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241849(US9416139, 27)
Affinity DataEC50:  1.53nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241850(US9416139, 28)
Affinity DataEC50:  1.10nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241851(US9416139, 29)
Affinity DataEC50:  0.0610nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241852(US9416139, 30)
Affinity DataEC50:  0.336nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241853(US9416139, 31)
Affinity DataEC50:  5.87nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241854(US9416139, 32)
Affinity DataEC50:  10.3nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241855(US9416139, 33)
Affinity DataEC50:  0.0780nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241856(US9416139, 34)
Affinity DataEC50:  0.641nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241857(US9416139, 35)
Affinity DataEC50:  10.6nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [1973-2420](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241858(US9416139, 36)
Affinity DataEC50:  0.438nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein(HCV)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287983(US10087167, Compound 1001)
Affinity DataEC50:  45.4nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein(HCV)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287985(US10087167, Compound 2001)
Affinity DataEC50:  550nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein(HCV)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287986(US10087167, Compound 3001)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein(HCV)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287988(US10087167, Compound 3002)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein(HCV)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287989(US10087167, Compound 3003)
Affinity DataEC50:  25.2nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein(HCV)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287990(US10087167, Compound 4001)
Affinity DataEC50: >1.00E+3nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein(HCV)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287991(US10087167, Compound 4002)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein(HCV)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287992(US10087167, Compound 4003)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein(HCV)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287994(US10087167, Compound 4004)
Affinity DataEC50:  1.69E+3nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein(HCV)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287995(US10087167, Compound 4005)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein(HCV)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287997(US10087167, Compound 4006)
Affinity DataEC50:  550nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein(HCV)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287998(US10087167, Compound 4007)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein(HCV)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287999(US10087167, Compound 4008)
Affinity DataEC50:  107nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein(HCV)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288000(US10087167, Compound 4009)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 344 total ) | Next | Last >>
Jump to: